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DOI: 10.1016/j.ajpath.2010.12.015This Month in AJPMast Cells Promote Radiation Proctitis
Cancer patients treated with radiotherapy may develop
bowel complications resembling Crohn’s disease and ul-
cerative colitis due to mast cell hyperplasia and activation in
rectal tissue. To investigate the specific role played by mast
cells, Blirando et al (Am J Pathol 2011, 178:640–651) in-
duced experimental radiation proctitis in a mast cell-defi-
cient (Wsh/Wsh) mouse model. Irradiated control rodent
rectum showed mast cell hyperplasia, whereas Wsh/Wsh
mice exhibited tissue protection associated with increased
tissue neutrophil influx and expression of several inflamma-
tory mediators immediately following radiation exposure.
Expression of chymase, tryptase, and histamine by mast
cells increased proliferation and migration of human pri-
mary colonic smooth muscle cells, as well as their secretion
of proinflammatory molecules. Mast cells may thus disrupt
neutrophil-mediated tissue protection, thereby perpetuating
colonic wall inflammation and damage.
Getting MIFed about Skin Photodamage
UV radiation indirectly controls melanogenesis, and thus
premature aging and hyperpigmentation, through a para-
crine regulatory mechanism involving keratinocytes. Eno-
moto et al (Am J Pathol 2011, 178:679–687) examined the
role of macrophage migration inhibitory factor (MIF) in this
process. Protease-activated receptor-2, which is induced
after UV-B irradiation, was up-regulated by MIF in cultured
keratinocytes. Release of the melanogenic cytokine stem
cell factor, but not endothelin-1, by keratinocytes was stim-
ulated by MIF; however, MIF had no effect on melanin
synthesis in cultured human melanocytes. In an in vitro 3-D
human epidermal culture model, epidermal melanin content
was increased by MIF, but UV-B–stimulated melanin syn-
thesis was significantly down-regulated by an anti-MIF an-
tibody. Further, the back skin of MIF transgenic mice had
higher melanin content than that of wild-type mice after 12
weeks of UV-B exposure. These findings suggest that MIF
inhibitors may have promise in preventing and treating pho-
todamage by blocking melanogenesis.
Neutrophil Recruitment May Regulate Lyme
Arthritis Severity
Lyme disease results from infection with Borrelia burgdorferi,
and CD14/ mice infected with the bacterium exhibit en-
hanced disease. Using this model of Lyme arthritis, Sahay
et al (Am J Pathol 2011, 178:724–734) examined the par-
adoxically poor bacterial clearance in CD14/ mice de-
spite high levels of antimicrobial cytokines. CD14 deficiencyled to decreased activation of matrix metalloproteinase-9
(MMP-9) and reduced collagen degradation, which limited
neutrophil recruitment into joint spaces and impaired B.
burgdorferi clearance. These findings point to individual
variation in neutrophil-mediated clearance of B. burgdorferi
as an explanation for differences in the severity and dura-
tion of Lyme arthritis in the patient population, suggesting
avenues for development of adjunctive therapy designed to
augment host immunity.
Increasing Muscle Bulk in Congenital
Myopathy
X-linked myotubular myopathy (XLMTM) is a congenital my-
opathy that often presents with severe perinatal weakness
requiring mechanical ventilation for survival. Since XLMTM
muscle exhibits small myofibers, Lawlor et al (Am J Pathol
2011, 178:784–793) postulated that therapeutically in-
creasing muscle fiber size would attenuate symptoms in
myotubularin-deficient (Mtm14) mice. Muscle hypertrophy
was induced with a soluble form of activin receptor type IIB
(ActRIIB-mFC), which is known to increase muscle mass in
myostatin-deficient mice. ActRIIB-mFC–treated Mtm14
mice lived longer and exhibited transient increases in
weight, forelimb grip strength, and myofiber size. Muscle
hypertrophy only occurred in type 2b myofibers, implying
that oxidative fibers in myotubularin-deficient animals are
incapable of a hypertrophic response. These results sug-
gest therapeutic possibilities for improving muscle weak-
ness of myotubularin deficiency.
Expression Signature for Aggressive
Endometrial Cancer
In endometrial cancer, vascular invasion is a feature of
aggressive tumors with reduced survival. In an effort to
identify a gene signature of vascular invasion, Mannelqvist
et al (Am J Pathol 2011, 178:861–871) used DNA micro-
array and quantitative PCR techniques to investigate the
gene expression pattern of 57 primary endometrial cancers.
They identified 18 genes (related to epithelial-mesenchymal
transition, wound response, endothelial cells, and VEGF
activity) that were significantly associated with patient sur-
vival and clinicopathologic phenotype. Immunohistochem-
istry validated the involvement of collagen 8 (COL8) and
matrix metalloproteinase 3 (MMP3) in vascular invasion and
angiopoietin-related protein 4 (ANGPTL4) and interleukin-8
(IL8) in patient survival. These findings identify gene expres-
sion profiles and suggest targets for metastatic spread and
improved management of endometrial cancer.
461
